Previously I’ve discussed the impact of new accounting rules on valuing of deworming medicine. Have been looking at Feed the Children financial statements to quantify the impact.
I am not picking on Feed the Children.
I’m using their 2010 financial statements because they have the best disclosures in their financial statements that I’ve seen for the impact, plus there is public information on what per-pill valuation amounts they have been using. It is to their credit that they have this amount of background available in their financial statements.
It is my guess, just a guess, that the same underlying valuation issues and impact on supporting services ratio that I have described previously here and here, would also be present in the financial information for other organizations that have large volumes of deworming medicine. If I can find good info, I’ll do some calculations on other sets of financials.
I have a few more observations and then one more set of calculations.